Safety and Efficacy of Certolizumab Pegol over 96 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
Author(s):
Sieper, J.; Rudwaleit, M.; Heijde, D.M. van der; Maksymowych, W.P.; Dougados, M.; Mease, P.; Braun, J.; Deodhar, A.A.; Hoepken, B.; Nurminen, T.; Landewe, R.B.M.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-10-31
Language
English
Is part of
Arthritis and Rheumatology (2014), Vol. 66, p. S376-S377
